President
CurrentVycellix, Inc. is a privately-held biopharmaceutical company developing innovative products capable of optimizing human immune response against disease with a focus on cancers. The Company is advancing its proprietary pipeline of novel immunodudulators as therapeutics for cancers and infectious disease, as well as establishing these molecules as platform.